|
LYPD6 expression based on
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.629100E-04 |
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.064400E-01 |
| Normal-vs-Stage2 |
5.797800E-02 |
| Normal-vs-Stage3 |
5.6843418860808E-14 |
| Normal-vs-Stage4 |
3.80650000408878E-09 |
| Stage1-vs-Stage2 |
6.202600E-01 |
| Stage1-vs-Stage3 |
8.463700E-02 |
| Stage1-vs-Stage4 |
1.106370E-01 |
| Stage2-vs-Stage3 |
4.436000E-01 |
| Stage2-vs-Stage4 |
4.845800E-01 |
| Stage3-vs-Stage4 |
8.889000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.197700E-02 |
| Normal-vs-AfricanAmerican |
6.83875178708604E-12 |
| Normal-vs-Asian |
5.80300252295274E-11 |
| Caucasian-vs-AfricanAmerican |
2.720400E-02 |
| Caucasian-vs-Asian |
6.861500E-02 |
| AfricanAmerican-vs-Asian |
3.775000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.16222611931971E-13 |
| Normal-vs-Female |
2.784200E-02 |
| Male-vs-Female |
3.866400E-02 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.69040004005927E-09 |
| Normal-vs-Age(41-60Yrs) |
4.796500E-02 |
| Normal-vs-Age(61-80Yrs) |
2.08089999998995E-05 |
| Normal-vs-Age(81-100Yrs) |
1.25989996213605E-09 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.722400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.916400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.720800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.203600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.017990E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.528000E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.949760E-02 |
| Classical-VS-Follicular |
2.438000E-02 |
| Classical-VS-Other |
4.447800E-01 |
| Classical-VS-Normal |
2.308300E-02 |
| Tall-VS-Follicular |
6.865400E-01 |
| Tall-VS-Other |
3.534200E-01 |
| Tall-VS-Normal |
1.67210689738795E-12 |
| Follicular-VS-Other |
3.572400E-01 |
| Follicular-VS-Normal |
1.69675384853463E-12 |
| Other-VS-Normal |
5.559800E-01 |
|
|
*
Please note that the TPM values for gene considered is extremely low (TPM < 1).
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.448400E-01 |
| Normal-vs-N1 |
3.24185123190546E-14 |
| N0-vs-N1 |
2.629800E-02 |
|
|
